Latest Period
Q2 2026
Security Snapshot
ONCOLYTICS BIOTECH INC - COM NEW (ONCY) Institutional Ownership
CUSIP: 68237V103
13F Institutional Holders and Ownership History from Q1 2026 to Q2 2026
Institutions Reporting
75
Shares (Excl. Options)
3,930,872
Price
$0.95
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / COM NEW
- Symbol
- ONCY on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 3,930,872
- Total 13F value
- $3,722,908
- Portfolio coverage rank
- 0%
- Share change
- +3,049,786
- Value change
- +$2,885,889
- Number of holders
- 75
- SEC-reported price per share
- $0.80
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
1 identity field
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- ONCY - ONCOLYTICS BIOTECH INC - COM NEW is tracked under CUSIP 68237V103.
- 75 institutions reported positions in Q2 2026.
- Schedule 13D/13G significant owner rows are not currently available.
Change
- Holder count moved from 2 to 75 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $731,039 to $3,722,908.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 75 institutions filings for Q2 2026.
Security key
68237V103
Latest holder period
Q2 2026
13F holders
75
13D/G owners
0
CIK / CUSIP context first
Open Q2 2026 holders
ONCY full holder history
ONCOLYTICS BIOTECH INC SEC filings
ONCOLYTICS BIOTECH INC company facts
ONCOLYTICS BIOTECH INC insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 68237V103:
As of 30 Jun 2026, 75 institutional investors reported holding 3,930,872 shares of ONCOLYTICS BIOTECH INC - COM NEW (ONCY).
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
2
Latest
Q2 2026
Rows shown
1-2 of 2